Telavancin · Vibativ, TD-6424

What is Telavancin?

Telavancin is a lipoglycopeptide antibacterial drug that inhibits bacterial cell wall synthesis.

Summary written with AI from the sources listed at the end of this page.

At a glance

Also known as

Vibativ, TD-6424

Drug type

Small molecule

Targets

bacterial cell wall

Mechanism

Inhibitor of bacterial cell wall

Therapy area

Infectious disease

Developer

Apotex

In trials of

CPIX

FDA status

Approved as Vibativ (September 11, 2009), NDA022110 · FDA label

UNII

0701472ZG0

✅ FDA-approved uses

• Complicated skin and skin structure infections
• Hospital-acquired and ventilator-associated bacterial pneumonia

From the indications section of the FDA label (version of Dec 19, 2025). Read the full label for the exact wording, limitations and safety information.

🧪 Clinical trials

Trials of the companies BioRadar tracks, from ClinicalTrials.gov, most advanced phase first.

Conditions studied

Subarachnoid Hemorrhage, AneurysmalBacteremiaPregnancy

Sources

• FDA label (DailyMed)
• FDA label Vibativ (2025-12-19), indications
• ClinicalTrials.gov NCT06119061

Updated Oct 3, 2026.